Medistem Shareholder Alert: Former SEC Attorney Willie Briscoe and Powers
Taylor LLP Investigate Acquisition by Intrexon
DALLAS -- December 20, 2013
Former United States Securities and Exchange Commission attorney Willie
Briscoe and the securities litigation firm of Powers Taylor LLP are
investigating potential claims against the Board of Directors of Medistem,
Inc. (OTCBB: MEDS) related to the acquisition by Intrexon Corporation for
shareholders. Under the terms of the definitive agreement valued at
approximately $26 million, Medistem shareholders will only receive $0.27 in
cash and $1.08 worth of Intrexon common stock for each share of MEDS stock
owned, well below the 52-week high of $2.80.
If you are an affected investor, and you want to learn more about the lawsuit
or join the action, contact Willie Briscoe at The Briscoe Law Firm, PLLC,
(214) 239-4568, or via email at WBriscoe@TheBriscoeLawFirm.com, or Zach
Groover at Powers Taylor LLP, toll free (877) 728-9607, via e-mail at
email@example.com. There is no cost or fee to you.
The Medistem investigation centers on whether Medistem’s Board of Directors is
acting in the shareholders’ best interests, whether the board is properly
considering the proposed price for the shareholders, and whether the board has
employed an adequate process to review and act on the proposed transaction.
The Briscoe Law Firm, PLLC is a full service business litigation and
shareholder rights advocacy firm with more than 20 years of experience in
complex litigation and transactional matters.
Powers Taylor LLP is a boutique litigation law firm that handles a variety of
complex business litigation matters, including claims of investor and
stockholder fraud, shareholder oppression, shareholder derivative suits, and
security class actions.
The Briscoe Law Firm, PLLC
Willie Briscoe, 214-239-4568
Powers Taylor LLP
Zach Groover, 877-728-9607
Press spacebar to pause and continue. Press esc to stop.